Section Review: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Is there a role for antacids in the modern management of peptic ulcers?

References

• CROHN BB, ROSENAK BD: An exhibition of books shownat the Graduate Fortnight illustrating the progress of gastroenterology. Bulletin of New York Academy of Medi-cine (1935) 11:74.
   Google Scholar
• SIPPY BW: Gastric and duodenal ulcers, medical cure byan efficient removal of gastric juice corrosion. JAMA (1915) 64:1625.
   Google Scholar
• SCHWARZ K: Ueber penetrierende Magen und Jejunal-gesch wure. Beitrage zur Klinische Chirurgie (1910) 67:95.
   Google Scholar
• PICKERING GW. Abdominal pain. In: Modern Trends in Gastroenterology (Volume 1, Chapter 4). Jones FA (Ed.), Bumerworths, London (1952).
   Google Scholar
• LAM SK, LAM KC, LAI CL et al.: Treatment of duodenal ulcer with antacid and sulpiride: a double-blind control-led study. Gastroenterology (1979) 76:315–322.
   PubMed Web of Science ®Google Scholar
• PETERSON WL, STURDEVANT RAL, FRANKL HD, RICHARD- ?SON CT, ISENGERN JL et al.: Healing of duodenal ulcer with an antacid regimen. NewEngl.J. Med. (1977) 297:341–345.
   Google Scholar
• LAM SK: Antacids: past, present and future. In: PepticUlcer. Clinics in Gastroenterology. Piper (Ed.), WB Saunders & Co., London, Philadelphia, Toronto (1988) 2:641–654.
   Google Scholar
• JONES DB, HOWDEN CW, BURGET OW, ICERR GD, HUNTRH: Add suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut (1987) 28:1120–1127.
   PubMed Web of Science ®Google Scholar
• FORD'TRAN JS, MORAWSKI, SG, RICHARDSON CT: In vivoand in vitro evaluation of liquid antacids. New Engl. J. Med. (1973) 288:923–928.
   PubMed Web of Science ®Google Scholar
• FORDTRAN JS: Reduction of acidity by diet, antacids andanticholinergic agents. In: Gastrointestinal diseases (1st Edition). Sleisenger, Fordtran (Eds.), WB Saunders & Co. (1973):718–742.
   Google Scholar
• FORDTRAN JS, COLLYNS JAH: Antacid pharmacology in duodenal ulcer. New Engl. J. Med. (1966) 274:921.
   PubMed Web of Science ®Google Scholar
• SIMMONS TC, HOGAN DL, SELLING JA, MAXWELL V, ISENBERG JI: The effect of sodium bicarbonate versus aluminium-magnesium hydroxide on postprandial gastric acid in duodenal ulcer patients. J. Clin. Gasmen-terol. (1986) 8:146–149.
   Web of Science ®Google Scholar
• DEERING TB, MALAGELADA J-R: Comparison of an H2 receptor antagonist and a neutralising antacid on post-prandial acid delivery in patients with duodenal ulcer. Gastroenterology (1977). 73:11–14.
   PubMed Web of Science ®Google Scholar
• CLAIN JE, MALAGELADA JR, CHAD WICK VS: Binding prop-erties in vitro of antacids for conjugated bile acids. Gastroenterology (1977) 73:556–559.
   PubMed Web of Science ®Google Scholar
• BERSTAD A, RYDNING A, AADLAND E, KOLSTAD B, FRIS-LID K et al.: Controlled clinical trial of duodenal ulcer healing with antacid tablets. Scand. J. Gastroenterol. (1982) 17:953–959.
   PubMed Web of Science ®Google Scholar
• FAIZALLAH R, DE HAAN HA, KRASNER N, WALKER RJ, MORRIS Al et al.: Is there a place in the United Kingdom for intensive antacid treatment for chronic peptic ul-ceration? Br. Med. J. (1984) 289:869–871.
   Google Scholar
• KUMAR N, Vii JC, KAROL A, ANAND BS: Controlled •therapeutic trial to determine the optimum dose of antacids in duodenal ulcer. Gut (1984) 25:1199–1202.
   PubMed Web of Science ®Google Scholar
• WEBERG R, BERSTAD A, LANGE 0, SCHULTZ T, AUBERTE: Duodenal ulcer healing with four antacid tablets daily. Scand. J. Gasteroenterol. (1985) 20:1041–1045.
   PubMed Web of Science ®Google Scholar
• IPPOLITI AF, STURDEVANT RAL, ISENBERG JI, BINDER M,CAMACHO R et al.: ametidine versus intensive antacid therapy for duodenal ulcer. A multicenter triaL Gas-troenterology (1978) 74:393–395.
   Google Scholar
• FEDELI G, ANTI M, RAPACCINI GL, DE VITIS I, BUTTI A etal.: A controlled study comparing cimetidine treatment to an intensive antacid regimen in the therapy of uncomplicated duodenal ulcer. Dig. Dis. Sci. (1979) 24:758–762.
   Google Scholar
• LAURITSEN K, BYTZER P, HANSEN J, BEKKER C, RASK-MADSEN J: Comparison of ranitidine and high-dose antacid in the treatment of prepyloric or duodenal ulcer: a double-blind controlled triaL Scand.J. Gastroen-terol. (1985) 20:123–128.
   Web of Science ®Google Scholar
• BIANCHI PORRO G, LAZZARONI M, PACE F, PETRILLO M:Long-term low-dose antacids versus cimetidine in the short-term treatment of duodenal ulcer. J. Gun. Gastroen-terol. (1986) 8:141–145.
   Web of Science ®Google Scholar
• LUX G, HENSCHEL H, ROHNER HG, BRUNNER H, SCHUTZE K et al.: Treatment of duodenal ulcer with low-dose antacids. Scand. J. Gastroenterol. (1986) 21:1063–1068.
   PubMed Web of Science ®Google Scholar
• BECKER U, LINDORFF K, ANDERSON C, RANLOV PJ: Ant- acid treatment of duodenal ulcer. Acta Medica Scandi-navica (1987) 221:95–101.
   PubMed Web of Science ®Google Scholar
• WEBERG R, AUBERT E, DAHLBERG 0. DYBDAHO J, ELLEKJAER E et al.: Low dose antacids or cimetidine for duodenal ulcer? Gastroenterology (1988) 95:1465–1469.
   Google Scholar
• HOLLANDER D, HARLAN J: Antacids vs. placebos in peptic ulcer therapy: a controlled double-blind investi-gation. JAMA (1973) 226:1181–1185.
   Google Scholar
• RYDNING A, WEBERG R, LANGE 0, BERSTAD A: Healing of benign gastric ulcer with low-dose antacids and fibre diet. Gastroenterology (1986) 91:56–61.
   PubMed Web of Science ®Google Scholar
• ISENBERG JI, PETERSON WL, ELASHOFF JD, SANDERSFELD MA, REEDY TJ etal.: Healing of benign gastric ulcer and low-dose antacid or cimetidine: a double-blind, ran-domised, placebo-controlled trial. New Engl. J. Med. (1983) 308:1319–1324.
   Google Scholar
• PACE F, BROKER HJ, CASPRAY W, FEURLE G, FIMMEL CJ et al.: Therapy of stomach ulcer with low-dose antacid gel and cimetidine: a multicenter double-blind study. Deutsche Medizinische Wochensch rift (1985) 22:283–287.
   Google Scholar
• WILCOX CM, SPENNEY JG: Stress ulcer prophylaxis in medical patients: who, what and how much? Am. J. Gastroenterol. (1988) 83:1199–1211
   Web of Science ®Google Scholar
• LAM SK, HUT WM: Is stress ulcer bleeding still an obnox-ious killer in present day ICU? J. Gastroenterol. Hepatol. (1992) 7:553–555.
   Google Scholar
• DRIKS MR, CRAVEN DE, CELLI BR et al.: Nosocomialpneumonia in intubated patients randomized to sucral-fate versus antacids and/or histamine type 2 blockers: the role of gastric colonization. New Engl. J. Med. (1987) 317:1376–1382.
   PubMed Web of Science ®Google Scholar
• BERSTAD A, WEBERG R: Antacids in the treatment ofgastroduodenal ulcer. Scand. J. Gastroenterol. (1986) 21:384–391.
   Google Scholar
• HARRISON A, ISENBERG JI, SCHAPIRA M, HAGIE L: Most patients with active symptomatic duodenal ulcers fail to develop ulcer-type pain in response to gastroduode-nal acidification. J. Clin. Gastroenterol. (1982) 4:105–108.
   PubMed Web of Science ®Google Scholar
• RANG JY, YAP I, GUAN K, TAY HH: Acid perfusion of duodenal ulcer craters and ulcer pain: a controlled double-blind study. Gut (1986) 27:942–945.
   PubMed Web of Science ®Google Scholar
• STURDEVANT RAL, ISENBERG JI, SECRIST D, ANSFIELD J: Antacid and placebo produced similar pain relief in duodenal ulcer patients. Gastroenterology (1977) 72:1–5.
   PubMed Web of Science ®Google Scholar
• RUNE SJ, ZACHARIASSON A: Acute relief of epigastric pain by antacid in duodenal ulcer patients. Scand. J. Gastroenterol. (1980) 15\(Suppl. 58)41–45.
   Google Scholar
• LAM SK. Academic investigator's perspectives of medi-cal treatment for peptic ulcer. In: Ulcer Disease: Investiga-tion and Basis for Therapy. Swabb, Szabo (Eds.), Marcel Dekker, New York (1991):431–450.
   Google Scholar
• BAKER LRI, ACKR1LL P, CASTELL WR: latrogenic osteo-malacia and myopathy due to phosphate depletion. Br. Med. J. (1974) 3:150–152.
   PubMed Web of Science ®Google Scholar
• British National Formukny, No. 29. British Medical Associa-tion and Royal Pharmaceutical Society of Great Britain, London (1995).
   Google Scholar
• NAGY EJOBST K: The kinetics of aluminium-containingantacid absorption in man. Eur. J. Clin. Chem. Clin. Biochem. (1994) 32:119–121.
   PubMedGoogle Scholar
• ABREO K, ADLAKHA A, KILPATRICK S, FALNAGAN R, WEBB R, SHAKAMURI S: The milk-alkali syndrome. A reversible form of renal failure. Arch. Intern. Med. (1993), 153:1005–1010.
   PubMed Web of Science ®Google Scholar
• HOUBEN G, HOOI J, HAMEETEMAN W, STOBBERINGH E,STOCKBRUGGER R: Intragastric bacterial overgrowth after short-term treatment of healthy subjects with various doses of add reducing drugs. Gastroenterology (1994) 106:A96.
   Google Scholar
• scarr H, NEAL KR, SLACK RCB, LOGAN RFA: Omeprazoletreatment, a potent risk factor for Campylobacter gas-troenteritis. Gastroenterology (1994) 106:A1049.
   Google Scholar
• COGHLAN JG, GILLIGAN D, HUMPHRIES H, MCKENNA D,DOOLEY C etal.: Campylobacter pylori and recurrence of duodenal ulcers - 12-months follow-up study. Lancet (1987) 2:1109–1111.
   Google Scholar
• MARSHALL BJ, GOODWIN CS, WARREN JR etal.: Prospec-tive double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet (1988) 2:1437–1441.
   Google Scholar
• RAUWS EAJ, TYTGAT GNJ: Cure of duodenal ulcer asso-ciated with eradication of Hellobacter pylori. Lancet (1990) 335:1233–1235.
   PubMedGoogle Scholar
• MOHAMED AH, WILKINSON J, HUNT RH: Duodenal ulcerrecurrence after Helicobacter pylori (Hp) eradication: a meta-analysis. Gastroenterology (1994) 106:A142.
   Web of Science ®Google Scholar
• CHIBA N, RAO By, RADEMAKER JW, HUNT RH: Meta-analysis of the efficacy of antibiotic therapy in eradicat-ing Helicobacter pylori. Am. J. Gastmenwrol. (1992) 87:1716–1727.
   PubMed Web of Science ®Google Scholar
• LOUW JA, ZAK J, LUCKE W et al.: Triple therapy withsucralfate is as effective as triple therapy containing bismuth in eradicating Helicobacter pylori and reduc-ing duodenal ulcer relapse rates. Scand. J. GastroenteroL (1992) 27\(Suppl. 191):28:31.
   Google Scholar
• HU WHC, LAM SK, HO J eta!,: Gastric metaplasia, Hell-cobacterpylori and the healing and relapse of duodenal ulcers [Abstract]. J. Gastroenterol. Hepatol. (1993) 8\(Suppl. 2):S263.
   Google Scholar
• BARDHAN KD, BIANCHI PORRO G, BOSE K, DALY M, HINCHL1FFE RFC et al.: A comparison of two different doses of omeprazole versus ranit.idine in treatment of duodenal ulcers. J. Clin. Gastroenterol. (1986) 8:408–413.
   Google Scholar
• HUT WM, LAM SK, LAU WY, BRANICKI FJ, LAI CL et al.:Omeprazole (OME) vs. ranitidine (RAN) for duodenal ulcer (DU) - one-week, low-dose regimens and factors affecting healing [Abstract]. Gastroenterology (1987) 92:1443.
   Google Scholar
• STROM M, GOTTHARD R, BODEMAR G, WALAN A: Ant-acid/anticholinergic, cimetidine and placebo in the treatment of active peptic ulcers. Scand. J. Gastroenterol. (1981) 16:593–602.
   PubMed Web of Science ®Google Scholar
• TOMASETTI P, STANGHELLINI E, BONORAG G, VEZZAD-INI P, LABO G: Comparative trial on healing and relapse of duodenal ulcer treated with trithiozine or cimetidine. Curr. 7ber. Res. (1981) 29:517–524.
   Google Scholar
• HUT WM, LAM SK, LOK AS, NG M, LAI CL: Maintenance therapy for duodenal ulcer: a randomised controlled comparison of seven forms of treatment. Am. J. Med. (1992) 92:265–274.
   PubMed Web of Science ®Google Scholar
• BRESCI G, CAPRIA A, FEDERICI G, RINDI G, GELONI M:Prevention of relapse with various antiulcer drugs. Scand. J. Gastroenterol. (1986) 21\(Suppl. 121):58–62.
   Google Scholar
• COOK PJ, VINCENT-BROWN A, LEWIS SI, PERKS, JEWELLDP et al.: Carbenoxolone (Duogastrone) and cimetidine In the treatment of duodenal ulcer - a therapeutic trial. Scand. J. Gastroenterol. (1980) 15\(Suppl. 69:93–101.
   Google Scholar
• MARTIN DF, HOLLANDERS D, MAY SJ, RAVENSCROFT M,TWEEDLE DE et al.: Difference in relapse rates of duode-nal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet (1981) 1:7–10.
   Google Scholar
• LAM SK, HUI WM, NG MMT: The stomach. In: CurrentGastroenterology. Gitnick GL (Ed.), Yearbook Medical Pub-lishers, Chicago, London (1987):31–65.
   Google Scholar
• LAM SK: Why do ulcers heal with sucralfate? Scand.Gastroenterol. (1990) 25\(Suppl. 173):6–16.
   Google Scholar
• KONTUREK SJ, BRZOZOWSKI T, DROZDOWICZ D, NAUERT C: Cytoprotection by aluminium-and magne-sium-hydroxide-containing antacids in rats. Scand. J. Gastroenterol. (1989) 24:1113–1120.
   PubMed Web of Science ®Google Scholar
• KONTUREK SJ: New aspects of clinical pharmacology of antacids. J. Physiol. Pharmacol. (1993) 44:5–21.
   PubMedGoogle Scholar
• LAM SK: Implications of sucralfate-induced ulcer heal-ing and relapse. Am. J. Med. (1989) 86(Suppl. 6A):122–126.
   Google Scholar
• MOSHAL MG, GREGORY MA, PILLAY C, SPITAELS JM: Does the duodenal cell ever return to normal? A comparison between treatment with ciraetidine and De-NoL Scand. Gastroenterol. (1979) SuppL 54:48–51.
   Google Scholar
• SCHMASSMANN A, TARNAWSKI A, GERBER HA, FLOR-GERZI B, SANNER M, VARGA L, HALTER F: Antacid pro-vides better restoration of glandular structures within the gastric ulcer scar than omeprazole. Gut (1994) 35:896–904.
   PubMed Web of Science ®Google Scholar
• LAMBRECHT N, TRAUTMANN M, KOROLKIEWICZ R, LISKAY M, PESKAR BM: Role of eicosanoids, nitric oxide, and afferent neurons in antacid induced protection in the rat stomach. Gut (1993) 34:329–337.
   PubMed Web of Science ®Google Scholar
• PRECLIK G, STAGE EF, GERBER K, FETZER G, HORN H,DITCHUNEIT H: Stimulation of mucosa' prostaglandin synthesis in human stomach and duodenum by antacid treatment. Gut (1989) 30:148–152.
   PubMed Web of Science ®Google Scholar
• LAM SK: Treatment of duodenal ulcer with sucralfate. Scand. J. Gastroenterol. (1991) SuppL 185:22–28.
   Google Scholar
• GRAHAM DY, AGRAWAL NM, ROTH SH: Prevention of NSAID-induced gastric ulcer with misoprostol: mul-ticentre, double-blind, placebo-controlled triaL Lancet (1988) 2(8623):1277–1280.
   Google Scholar
• KONTUREK SJ, BRZOZOWSKI T, DEMBINSKI A, WAR-ZECHA Z, YAMAZAKI J: Gastric protective and ulcer-heal-ing action of epidermal growth factor. In: Advances in Drug Therapy of Gastrointestinal Ulceration. Garner A, Whit-tle BJR (Eds.), Wiley (1989).
   Google Scholar
• FOLKMAN J, SZABO S, STOVROFF M, NCNEIL P, LI W, SHING Y: Duodenal ulcer: discovery of a new mecha-nism and development of angiogenic therapy which accelerates healing. Ann. Surg. (1991) 214:414–427.
   PubMed Web of Science ®Google Scholar
• CIACCI C, LIND SE, PODOLSKY DK: Transforming growth factor fI regulation of migration in wounded rat intes-tinal epithelial monolayers. Gastroenterology (1993) 105:93–101.
   PubMed Web of Science ®Google Scholar
• NEXO E, POULSEN SS: Does epidermal growth factor play a role in the action of sucralfate? Scand. J. Gastroen-terol. (1987) 22\(Suppl. 127):45–49.
   Google Scholar
• BYTZER P, LAURITSEN K, RASK-MADSEN J: Symptomatic •recurrence of healed duodenal and pre-pyloric ulcers after treatment with ranitidine or high-dose antacid: a 1-year follow-up study. Scand. J. Gastroenterol. (1986) 21:765–768.
   PubMed Web of Science ®Google Scholar